Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to HCC
Related studies linked through entity extraction aliases.
Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
Population-wide Research for HBV-related Liver Diseases in Maoming City
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
- Status
- RECRUITING
- Phase
- NA
SALT for Liver Cirrhosis With HCC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study
- Status
- UNKNOWN
- Phase
- N/A
A New Conception About Individualized Treatment Allocation for HCC
- Status
- COMPLETED
- Phase
- N/A
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CXD101 in Immunotherapy-related Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of Serum Tumor Markers of HBV Associated HCC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial
- Status
- RECRUITING
- Phase
- NA
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- N/A
Artificial Intelligence and Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC
- Status
- UNKNOWN
- Phase
- NA
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3